Thomas Woiwode Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Thomas Woiwode.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Thomas Woiwode. Thomas Woiwode is Director in Adverum Biotechnologies, Inc. ($AAVL) and Director in Audentes Therapeutics, Inc. ($BOLD) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Gritstone Oncology, Inc. ($GRTS) and Director in Passage BIO, Inc. ($PASG) and Director in Aligos Therapeutics, Inc. ($ALGS).

Latest Insider Trading Transactions of Thomas Woiwode

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADVM, ALGS, BOLD, CRSP, GRTS, PASG

Page: 1 2 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 28 2021	PASG	Passage BIO, Inc.	Woiwode Thomas	Director	Option Exercise	A	13.83	16,918	233,976	16,918
May 14 2021	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Option Exercise	A	3.70	40,000	148,000	40,000
Apr 28 2021	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	2,226	0	2,226	0 to 2.2 K
Apr 28 2021	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	8,385	0	0	8.4 K to 0 (-100.00 %)
Apr 28 2021	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	8,385	0	8,385	0 to 8.4 K
Apr 28 2021	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	9,720	0	0	9.7 K to 0 (-100.00 %)
Apr 28 2021	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	9,720	0	9,720	0 to 9.7 K
Apr 28 2021	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	485,979	0	1,943,916	2.4 M to 1.9 M (-20.00 %)
Jan 04 2021	GRTS	Gritstone Oncology ...	Woiwode Thomas	Director	Buy	P	3.71	1,347,709	5,000,000	1,347,709	0 to 1.3 M
Dec 16 2020	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Buy	J	0.00	12,783	0	18,822	6 K to 18.8 K (+211.67 %)
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	198,485	0	0
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	85,065	0	0
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	463,959	0	0
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	198,839	0	0
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	2,145,991	0	0
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Buy	P	15.00	200,000	3,000,000	862,444	662.4 K to 862.4 K (+30.19 %)
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	198,485	0	662,444	464 K to 662.4 K (+42.78 %)
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	463,959	0	463,959	0 to 464 K
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	85,065	0	2,429,895	2.3 M to 2.4 M (+3.63 %)
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	198,839	0	2,344,830	2.1 M to 2.3 M (+9.27 %)
Oct 20 2020	ALGS	Aligos Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	2,145,991	0	2,145,991	0 to 2.1 M
Jun 25 2020	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Option Exercise	A	25.64	30,000	769,200	30,000
Jun 22 2020	GRTS	Gritstone Oncology ...	Woiwode Thomas	Director	Option Exercise	A	6.66	12,500	83,250	12,500
Mar 02 2020	PASG	Passage BIO, Inc.	Woiwode Thomas	Director	Option Exercise	A	18.00	33,836	609,048	33,836
Aug 02 2019	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Option Exercise	A	13.41	45,000	603,450	45,000
Jun 20 2019	GRTS	Gritstone Oncology ...	Woiwode Thomas	Director	Option Exercise	A	10.86	8,570	93,070	8,570
Oct 02 2018	GRTS	Gritstone Oncology ...	Woiwode Thomas	Director	Option Exercise	C	0.00	929,020	0	0
Oct 02 2018	GRTS	Gritstone Oncology ...	Woiwode Thomas	Director	Option Exercise	C	0.00	2,173,909	0	0
Oct 02 2018	GRTS	Gritstone Oncology ...	Woiwode Thomas	Director	Buy	C	0.00	3,102,929	0	3,102,929	0 to 3.1 M
Jun 15 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	A	59.31	30,000	1,779,300	30,000
Jun 15 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	A	59.31	30,000	1,779,300	30,000
Jun 15 2018	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Option Exercise	A	6.25	35,000	218,750	35,000
May 17 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	58.73	1,000	58,730	640,014	641 K to 640 K (-0.16 %)
May 17 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	57.97	43,000	2,492,710	641,014	684 K to 641 K (-6.29 %)
May 09 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.45	1,653	85,047	5,629	7.3 K to 5.6 K (-22.70 %)
May 09 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.26	582	29,833	90,730	91.3 K to 90.7 K (-0.64 %)
May 09 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.26	249	12,764	38,772	39 K to 38.8 K (-0.64 %)
May 09 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.26	225	11,534	34,977	35.2 K to 35 K (-0.64 %)
May 09 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.26	7,645	391,883	1,192,139	1.2 M to 1.2 M (-0.64 %)
May 09 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.31	7,424	373,501	91,312	98.7 K to 91.3 K (-7.52 %)
May 09 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.31	3,172	159,583	39,021	42.2 K to 39 K (-7.52 %)
May 09 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.31	2,862	143,987	35,202	38.1 K to 35.2 K (-7.52 %)
May 09 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.31	97,550	4,907,741	1,199,784	1.3 M to 1.2 M (-7.52 %)
May 02 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.29	2,044	102,793	98,736	100.8 K to 98.7 K (-2.03 %)
May 02 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.26	874	43,927	42,193	43.1 K to 42.2 K (-2.03 %)
May 02 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.29	788	39,629	38,064	38.9 K to 38.1 K (-2.03 %)
May 02 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.29	26,860	1,350,789	1,297,334	1.3 M to 1.3 M (-2.03 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.03	779	38,973	100,780	101.6 K to 100.8 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.03	779	38,973	100,780	101.6 K to 100.8 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.01	333	16,653	43,067	43.4 K to 43.1 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.01	333	16,653	43,067	43.4 K to 43.1 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.08	300	15,024	38,852	39.2 K to 38.9 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.08	300	15,024	38,852	39.2 K to 38.9 K (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.02	10,236	512,005	1,324,194	1.3 M to 1.3 M (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.02	10,236	512,005	1,324,194	1.3 M to 1.3 M (-0.77 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.11	14,086	705,849	101,559	115.6 K to 101.6 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.11	14,086	705,849	101,559	115.6 K to 101.6 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.12	6,019	301,672	43,400	49.4 K to 43.4 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.12	6,019	301,672	43,400	49.4 K to 43.4 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.12	5,430	272,152	39,152	44.6 K to 39.2 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.12	5,430	272,152	39,152	44.6 K to 39.2 K (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.11	185,075	9,274,108	1,334,430	1.5 M to 1.3 M (-12.18 %)
Apr 30 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.11	185,075	9,274,108	1,334,430	1.5 M to 1.3 M (-12.18 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	1,528	77,928	115,645	117.2 K to 115.6 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	653	33,303	49,419	50.1 K to 49.4 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.60	589	29,803	44,582	45.2 K to 44.6 K (-1.30 %)
Apr 26 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	20,071	1,023,621	1,519,505	1.5 M to 1.5 M (-1.30 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.66	6,821	345,552	117,173	124 K to 117.2 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	2,915	148,665	50,072	53 K to 50.1 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	51.00	2,630	134,130	45,171	47.8 K to 45.2 K (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	50.66	89,628	4,540,554	1,539,576	1.6 M to 1.5 M (-5.50 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	2,323	0	7,282	5 K to 7.3 K (+46.84 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	92,918	0	0	92.9 K to 0 (-100.00 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	92,918	0	92,918	0 to 92.9 K
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	2,947	0	13,277	16.2 K to 13.3 K (-18.16 %)
Apr 24 2018	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	497,053	0	2,238,979	2.7 M to 2.2 M (-18.17 %)
Dec 27 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	20.29	3,059	62,070	4,959	8 K to 5 K (-38.15 %)
Nov 28 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	20.24	200	4,048	8,018	8.2 K to 8 K (-2.43 %)
Nov 28 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	S	20.21	1,700	34,358	8,218	9.9 K to 8.2 K (-17.14 %)
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	9,918	0	9,918	0 to 9.9 K
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	1,240	0	0	1.2 K to 0 (-100.00 %)
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	1,240	0	1,240	0 to 1.2 K
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	17,283	0	0	17.3 K to 0 (-100.00 %)
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	17,283	0	17,283	0 to 17.3 K
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	292,529	0	0	292.5 K to 0 (-100.00 %)
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	J	0.00	292,529	0	292,529	0 to 292.5 K
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	26,491	0	52,987	79.5 K to 53 K (-33.33 %)
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	61,993	0	123,994	186 K to 124 K (-33.33 %)
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	23,899	0	47,801	71.7 K to 47.8 K (-33.33 %)
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	814,599	0	1,629,204	2.4 M to 1.6 M (-33.33 %)
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	8,110	0	16,224	24.3 K to 16.2 K (-33.33 %)
Sep 07 2017	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Sell	J	0.00	1,368,013	0	2,736,032	4.1 M to 2.7 M (-33.33 %)
Jun 14 2017	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Option Exercise	A	2.75	33,602	92,406	33,602
Jun 14 2017	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	22,727	0	70,380	47.7 K to 70.4 K (+47.69 %)
May 01 2017	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	2,223	0	47,653	45.4 K to 47.7 K (+4.89 %)
Apr 03 2017	ADVM	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,704	0	45,430	41.7 K to 45.4 K (+8.88 %)
Mar 02 2017	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,774	0	41,726	38 K to 41.7 K (+9.94 %)
Feb 02 2017	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,449	0	37,952	34.5 K to 38 K (+10.00 %)
Jan 03 2017	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,449	0	34,503	31.1 K to 34.5 K (+11.11 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	5,774	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	13,180	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	5,210	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	173,167	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	1,454	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	231,077	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	73,704	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	168,224	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	66,490	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	2,210,417	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	19,524	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	3,100,477	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	2,754	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	C	0.00	437,247	0	0
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	A	14.00	30,000	420,000	60,000
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	5,774	0	79,478	73.7 K to 79.5 K (+7.83 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	73,704	0	73,704	0 to 73.7 K
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	P	14.00	4,583	64,162	185,987	181.4 K to 186 K (+2.53 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	13,180	0	181,404	168.2 K to 181.4 K (+7.83 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	168,224	0	168,224	0 to 168.2 K
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	5,210	0	71,700	66.5 K to 71.7 K (+7.84 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	66,490	0	66,490	0 to 66.5 K
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	P	14.00	60,219	843,066	2,443,803	2.4 M to 2.4 M (+2.53 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	173,167	0	2,383,584	2.2 M to 2.4 M (+7.83 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	2,210,417	0	2,210,417	0 to 2.2 M
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	P	14.00	602	8,428	24,334	23.7 K to 24.3 K (+2.54 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	1,454	0	23,732	22.3 K to 23.7 K (+6.53 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	19,524	0	22,278	2.8 K to 22.3 K (+708.93 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	2,754	0	2,754	0 to 2.8 K
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	P	14.00	95,596	1,338,344	4,104,045	4 M to 4.1 M (+2.38 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	231,077	0	4,008,449	3.8 M to 4 M (+6.12 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	3,100,477	0	3,777,372	676.9 K to 3.8 M (+458.04 %)
Dec 23 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Buy	C	0.00	437,247	0	676,895	239.6 K to 676.9 K (+182.45 %)
Dec 01 2016	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,509	0	31,054	27.5 K to 31.1 K (+12.74 %)
Nov 01 2016	AAVL	Adverum Biotechnol ...	Woiwode Thomas	Director	Grant	A	0.00	3,390	0	27,545	24.2 K to 27.5 K (+14.03 %)
Oct 20 2016	CRSP	CRISPR Therapeutic ...	Woiwode Thomas	Director	Option Exercise	A	14.00	30,000	420,000	30,000
Aug 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Option Exercise	A	15.03	18,000	270,540	18,000
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Option Exercise	C	0.00	1,249	0	0
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Option Exercise	C	0.00	3,029	0	0
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Option Exercise	C	0.00	6,811	0	0
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Option Exercise	C	0.00	198,410	0	0
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Option Exercise	C	0.00	480,856	0	0
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Option Exercise	C	0.00	1,081,477	0	0
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Buy	P	15.00	219	3,285	11,308	11.1 K to 11.3 K (+1.97 %)
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Buy	P	15.00	34,781	521,715	1,795,524	1.8 M to 1.8 M (+1.98 %)
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Buy	C	0.00	1,249	0	11,089	9.8 K to 11.1 K (+12.69 %)
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Buy	C	0.00	3,029	0	9,840	6.8 K to 9.8 K (+44.47 %)
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Buy	C	0.00	6,811	0	6,811	0 to 6.8 K
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Buy	C	0.00	198,410	0	1,760,743	1.6 M to 1.8 M (+12.70 %)
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Buy	C	0.00	480,856	0	1,562,333	1.1 M to 1.6 M (+44.46 %)
Jul 25 2016	BOLD	Audentes Therapeut ...	Woiwode Thomas	Director	Buy	C	0.00	1,081,477	0	1,081,477	0 to 1.1 M

Page: 1 2 next >